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S U M M A R Y
Here we report a unique case of tuberculoid leprosy and cytomegalovirus retinitis in a 27-year-old
female patient with AIDS, suggestive of highly active antiretroviral therapy (HAART)-induced immune
restoration disease. After initiation of HAART, the patient presented with decreased visual acuity,
hypoesthetic patch with local nerve thickening, and an increase in her CD4+ T cell count. On further
investigations cytomegalovirus retinitis and tuberculoid leprosy were conﬁrmed. To our knowledge no
case with such a co-existence has previously been reported.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Immune restoration disease (IRD) is a clinical entity character-
ized by an excessive inﬂammatory response to a pre-existing
antigen or pathogen and a paradoxical deterioration in clinical
status after initiation of antiretroviral therapy (ART). Pre-existing
infections may have been previously diagnosed and treated or they
may be subclinical. In the case of rapid improvement of immune
function, particularly in patients with low CD4+ T cell counts,
systemic and local inﬂammatory reactions occur at the site of pre-
existing infection. Cytomegalovirus (CMV)-associated IRD may
manifest as CMV retinitis, immune recovery uveitis (IRU), or
immune recovery vitritis. IRD presenting with unmasking of
leprosy with or without lepra reactions has rarely been reported in
the literature.
2. Case report
A 27-year-old woman from North Bengal (India) was diagnosed
to be suffering from an HIV-1 infection after screening when her
husband was found to be HIV-infected. At the time of diagnosis she
was asymptomatic and her CD4+ T cell count was 76/ml, and after* Corresponding author. Tel.: +91 9903568369.
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highly active antiretroviral therapy (HAART) with stavudine +
lamivudine + nevirapine was initiated. After 15 days of HAART she
complained of painless gradual bilateral diminishing vision. A B-
scan ultrasonography (USG B) of both her eyes was done and
revealed bilateral exudative retinal detachment. She also devel-
oped a single erythematous, circumscribed skin lesion on her left
foot, which did not respond to topical antifungals. Her CD4+ T cell
count increased to 119/ml at 15 days after initiation of HAART.
Three months later she was referred to us.
Apart from the vision and skin lesion she had no other
complaints. She could count ﬁngers at up to 3 feet with the right
eye, but with the left eye only perception of light was present. A
well-deﬁned single erythematous, crusted, hypoesthetic lesion
over the dorsum of the left foot was present. This was associated
with thickening of the left superﬁcial peroneal nerve (Figure 1).
Other peripheral nerves were not thickened. No other signiﬁcant
abnormality was present on physical examination. Her CD4+ T cell
count had increased to 221/ml by this time. The HIV viral load could
not be estimated due to ﬁnancial constraints. Other laboratory
parameters were within normal limits. An X-ray of the chest and
ultrasonography of the abdomen were normal. On ophthalmosco-
py, bilateral massive perivasculitis with neovascularization at the
periphery along with tractional retinal detachment was present
(Figure 2). Slit lamp biomicroscopy of the left eye showed anterior
uveitis with posterior synechia and pigmentation on the lens. Theses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Tuberculoid leprosy lesion with superﬁcial peroneal nerve thickening.
Figure 3. Skin biopsy showing epithelioid granuloma with Langhans and foreign
body giant cells surrounded by lymphomononuclear cells.
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done because of ﬁnancial constraints. Acid-fast bacilli could not be
demonstrated in a slit skin smear of the skin lesion stained with
modiﬁed Ziehl–Neelsen method. A skin biopsy was done and it
showed hyperkeratosis with thinning and ﬂattening of rete ridges.
Epithelioid granuloma with Langhans cells (fusion of epithelioid
cells) and foreign body giant cells surrounded by lymphomono-
nuclear cells were present in the dermis (Figure 3). These ﬁndings
were consistent with tuberculoid leprosy. Ganciclovir (5 mg/kg
body weight twice daily for 3 weeks) with oral steroids, followed
by a maintenance dose of valganciclovir (900 mg/day) was given.
Therapy for tuberculoid leprosy with multidrug therapy consisting
of rifampin (600 mg once monthly) and dapsone (100 mg daily)
was prescribed. Nevirapine was changed to efavirenz to avoid any
drug interaction. There was mild improvement in vision after the
induction phase of ganciclovir and the tuberculoid lesion showed
considerable regression.
3. Discussion
IRD is a clinical entity characterized by an excessive inﬂamma-
tory response to a pre-existing antigen or pathogen and a
paradoxical deterioration in clinical status after initiation of
ART.1 Patients with advanced immunodeﬁciency at HAART
initiation are at greatest risk of developing IRD and should be
appropriately screened and monitored.
In the case described here, CMV infection of the retina appears
to have been ‘unmasked’ by an immune response against CMV.Figure 2. Ophthalmoscopy showing perivasculitis, neovascularization, and
exudate.Retinitis associated with CMV infection after commencing ART was
described by Jacobson et al. many years ago, although at the time it
was not recognized that the CMV disease resulted from the
restoration of an immune response.2 Floaters, loss of visual ﬁelds,
and blurring of vision are the most common presentations of CMV
retinitis, which mostly occur in patients with CD4 counts of <50–
100/ml.3 IRU is an intraocular inﬂammation that develops in
patients with inactive CMV retinitis who have had a substantial
elevation in CD4+ count with HAART. Clinical ﬁndings include
anterior chamber or vitreous reaction, panuveitis with hypopyon,
optic disk and cystoid macular edema, epiretinal membrane
formation, cataract, vitreomacular traction syndrome, and prolif-
erative vitreoretinopathy.4 As discussed in the above section there
was evidence of inﬂammation in the eye after initiating HAART, so
there was a component of IRU. Oral valganciclovir, intravenous (IV)
ganciclovir, IV ganciclovir followed by oral valganciclovir, IV
foscarnet, IV cidofovir, and the ganciclovir intraocular implant
coupled with valganciclovir, are all effective treatments for CMV
retinitis.5 In the case of IRU, treatment usually requires periocular
corticosteroids or short courses of systemic corticosteroids.5
In developing countries where leprosy is endemic, it is
theoretically possible that there will be an increase in cases as
well as severity of leprosy in HIV co-infected patients, as occurred
with tuberculosis. However none of these concerns have materi-
alized and the interaction between HIV and Mycobacterium leprae
appears to be far more subtle.6 To our knowledge only three cases
with tuberculoid leprosy and a type 1 lepra reaction have been
published in the past, but none occurred with coexisting CMV
disease. According to Deps and Lockwood, who have proposed a
new classiﬁcation for leprosy associated with IRD in AIDS after
reviewing the published data, HIV-infected patients with poor
immune recovery after initiation of HAART have subclinical
leprosy and those patients with an intermediate rate of immune
recovery develop leprosy with normal presentation. The occur-
rence of an atypical clinical presentation with ﬂorid lesions or
intense type 1 lepra reaction and neuritis occur in those patients
with a dysregulated immune recovery.7
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